WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.
更新时间：2025-07-11 直达：westvacpharma.com
暂无描述...
百仑生物科技（江苏）有限公司(www.china-bioreactor.com)是提供成套生物反应器的制造商与技术服务商,产品包括微生物发酵罐,智能发酵罐,玻璃发酵罐,大型发酵罐,实验发酵罐及生物反应器的控制系统等
MachTech,foundedin1996,specializesinproviding
青云作为技术领先的企业级云服务商与数字化解决方案提供商，坚持核心代码自研，构建端到端的数字化解决方案，持续打造云原生最佳实践，以中国科技服务数字中国。
弘阳集团1996年创立于江苏南京，业务涵盖商业运营、地产开发、物业服务等，致力于成为受人尊敬的美好生活创造者。集团旗下弘阳地产（01996.HK）和弘阳服务（01971.HK）在香港主板上市。
安庆公积金网,公积金查询
柳州市易泰活动板房有限公司是广西一家设计、制作、销售、维护柳州活动板房、柳州二手活动板房、柳州活动板房厂、柳州住人集装箱、柳州钢结构、广西活动板房、广西活动房、广西二手活动板房、广西活动板房厂家、广西活动板房安装的专业源头厂家，制造商。咨询热线：13657726360
吉林省春润生物科技有限公司_目前公司已经形成以“成味食品香精、复配贪品添加剂、消毒剂(二氧化氯》”为主导产品的生产体系。
蓝沙生物致力于采用对DNA、RNA、蛋白定量的生物学检测技术以及高性能计算方法，为社会提供精准、可靠的医学检验产品和服务。